Anja Klumpp
Overview
Explore the profile of Anja Klumpp including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
25
Followers
0
Related Specialties
Related Specialties
Co-Authors
Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Markert M, Stubhan M, Mayer K, Trautmann T, Klumpp A, Schuler-Metz A, et al.
J Pharmacol Toxicol Methods
. 2009 May;
60(1):79-87.
PMID: 19427912
Introduction: The objective of this study was to use a newly established cardiovascular model using freely moving minipigs to document the hemodynamic and electrocardiographic effects of known pharmacological agents. The...
2.
Stubhan M, Markert M, Mayer K, Trautmann T, Klumpp A, Henke J, et al.
J Pharmacol Toxicol Methods
. 2008 Apr;
57(3):202-11.
PMID: 18434212
Introduction: The objective of this study was to evaluate the normal cardiovascular and ECG parameters in freely moving minipigs and to use these data as the basis of pharmacological drug...
3.
Markert M, Klumpp A, Trautmann T, Mayer K, Stubhan M, Guth B
J Pharmacol Toxicol Methods
. 2007 Jun;
56(2):203-11.
PMID: 17583538
Introduction: The objective of this study was to define the normal LVdP/dt (an index of myocardial contractility)-heart rate relationship in telemetered conscious dogs, primates and mini-pigs in our laboratory and...
4.
Klumpp A, Trautmann T, Markert M, Guth B
J Pharmacol Toxicol Methods
. 2006 May;
54(2):141-9.
PMID: 16730461
Introduction: The objective of this study was to test the influence of housing conditions on hemodynamics during cardiovascular general pharmacological studies. Our goal was to optimize both the quality of...
5.
Markert M, Klumpp A, Trautmann T, Guth B
J Pharmacol Toxicol Methods
. 2004 Sep;
50(2):109-19.
PMID: 15385085
Introduction: Estimation of possible cardiovascular side effects belongs to the safety assessment of every drug candidate. This paper describes a new strategy for treating conscious labrador dogs with drugs by...